Recruiting × Neoplasms × Other hematologic neoplasm × Clear all CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Phase 1/2 Recruiting
152 enrolled
PRAGMATIC
Phase 2 Recruiting
104 enrolled
QUATRO-APL
Phase 3 Recruiting
150 enrolled
Massage Impact on Sleep in Pediatric Oncology
Phase NA Recruiting
70 enrolled
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 2 Recruiting
80 enrolled
Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Recruiting
6,000 enrolled
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Phase 2 Recruiting
496 enrolled
PROVIDENCE
Recruiting
132 enrolled
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Phase 1 Recruiting
42 enrolled
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Recruiting
625 enrolled
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Recruiting
1,100 enrolled
UR-GOAL RCT
Phase NA Recruiting
1,020 enrolled
Longitudinal Studies of Patient With FPDMM
Recruiting
1,000 enrolled
ASAP
Recruiting
25,000 enrolled
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Phase 4 Recruiting
16 enrolled
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Phase 1 Recruiting
42 enrolled
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
Phase NA Recruiting
188 enrolled
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
Phase NA Recruiting
60 enrolled
SC-Het-GM-CCS
Recruiting
600 enrolled
Discontinuation Study
Phase NA Recruiting
70 enrolled
HORIZONS
Phase NA Recruiting
350 enrolled
BOOSTER
Recruiting
300 enrolled
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Phase 2 Recruiting
75 enrolled
The Florida ASCENT Study
Phase NA Recruiting
100 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Phase 1 Recruiting
150 enrolled
ReVenG
Phase 2 Recruiting
75 enrolled
This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 Recruiting
71 enrolled
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Phase 1 Recruiting
154 enrolled
MPGx-INDALL
Recruiting
556 enrolled
Response to Influenza Vaccination in Pediatric Oncology Patients
Recruiting
150 enrolled
A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients
Phase NA Recruiting
68 enrolled
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Phase NA Recruiting
60 enrolled
xDRIVE for Florida-based Cancer Patients
Phase NA Recruiting
210 enrolled
CAYA Cancer Retrospective Cohort Study
Recruiting
18,000 enrolled
Immune Profiling for Cancer Immunotherapy Response
Recruiting
1,500 enrolled
VeRVe
Recruiting
500 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
LIBERATE
Recruiting
2,500 enrolled
DETERMINE
Phase 2/3 Recruiting
825 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
DETERMINE
Phase 2/3 Recruiting
30 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
BMT-CARE
Phase NA Recruiting
800 enrolled
PEDALL
Phase NA Recruiting
376 enrolled
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/3 Recruiting
900 enrolled